TRINITY BIOTECH (UK) LIMITEDActive
Key figures
Ratios
2023Balance sheet structure
Filed accounts2020–2023
| 2020 | 2023 | |
|---|---|---|
| Turnover | 0 | 86,000 |
| Cash at bank and in hand | 8 | 2,000 |
| Total assets | 464 | 182,000 |
| Total liabilities | 403 | 243,000 |
| Net assets / total equity | 61 | 61,000 |
| Average number of employees | 2 | 1 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2023Trinity Biotech (UK) Limited (the “Company”) is part of the Trinity Biotech plc group (the “group”). The Company’s principal activity is to support other group companies. The Company does not carry out any manufacturing since the manufacturing facilities in the UK were closed in July 2014 and the operations were relocated to Bray, Ireland and Jamestown, New York.
As described in the company's latest filed accounts.
Summary: TRINITY BIOTECH (UK) LIMITED
Company
TRINITY BIOTECH (UK) LIMITED is a private limited company registered with Companies House under company number 08606499. It was incorporated on 11 Jul 2013. Its status is active. The registered office is in Cambridge (CB2). Its nature of business (SIC 2007) is other human health activities (86900).
Accounts
The latest accounts in the database are for 2023 (period ending 31 Dec 2023); the company files small company accounts (filleted). Turnover was £86,000. Net assets were £61,000, up 99,900% on the previous year. Cash at bank and in hand was £2,000. Total assets were £182,000 and total liabilities £243,000. The company had an average of 1 employee. Figures are available for 2 financial years (2020–2023).
Filing deadlines
The next accounts are due by 30 Sep 2025. The next confirmation statement is due by 12 May 2026.